Journal profile

Cancer Screening and Prevention

ISSN 2993-6314 · eISSN 2835-3315 · Xia & He Publishing Inc. · USA · Quarterly · Founded 2022

Cancer Screening and Prevention: fully open access; APC about USD 680; review about 20 days (submission to first decision, publisher); community-reported acceptance: 58%.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
Review time20 daysPublisher-reported, submission to first decision (includes desk rejections)
APCUSD 680Fully open access
Acceptance58%Community average
Articles per year—No count yet

Scope

Aims, scope and focus

Cancer Screening and Prevention (CSP) publishes high-quality research and review articles related to cancer screening and prevention. It aims to provide a platform for studies that develop innovative and creative strategies and precise models for screening, early detection, and prevention of various cancers. Studies on the integration of precision cancer prevention multiomics where cancer screening, early detection and prevention regimens can precisely reflect the risk of cancer from dissected genomic and environmental parameters are particularly welcome.Specifically, CSP publishes epidemiological, translational, and clinical studies on screening, early diagnosis, prevention of various cancers, especially gastrointestinal cancers. Topics of particular interest include but are not limited to:Epidemiology of cancersNew strategies or modelsNovel discoveries of biomarkersNovel devices and clinical applicationInnovative techniques and clinical applicationNovel theories and mechanismsEvidence-based medicineEarly detection of cancerPrecision cancer screening and preventionFuture perspectives The acceptable categories include original article, review article, systematic review, meta-analysis, short communication, letter to the editor, and invited editorial & commentaries on rapidly progressing areas within the scope. All articles published by CSP, both solicited and unsolicited, must have passed a rigorous peer review.

From the journal's Aims & Scope

Editor-in-chief Yiqi DuPublisher website

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

Indexed in: no record yet.

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Share of gold OA articles
0%LetPub ·

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average acceptance (community reports)
58%LetPub ·
Acceptance rate (publisher)
58%Publisher website ·
Submission to first decision
20 daysPublisher website ·
Peer review
Double anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
Publisher websiteUSD 680 / USD 450——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare2 items from the author guidelines
Reference style
Vancouver
Suggested reviewers
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted15, with length limits
  1. case reportCase Reports should describe an individual patient or series of patients (normally less than three) that presented with an unexpected or rare condition that has…main text ≤ 2,500 words · abstract ≤ 250 words · figures and tables ≤ 4 · references ≤ 25
  2. editorial, beginning with “Dear Editor(s),” ~ 10 Editorial ~ 1 ~ 1000 words; Unstructured ~ 10 Case Report Unstructured; No more than 2main text ≤ 1,000 words · figures and tables ≤ 1 · references ≤ 10
  3. hypothesisPlease ensure that any manuscript you submit to CSP conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internation…Length not stated
  4. letterPlease ensure that any manuscript you submit to CSP conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internation…main text ≤ 1,500 words
  5. letter to the editorLetter to the Editor ~ 1 ~ 800 words; Unstructured, beginning with “Dear Editor(s),” ~ 10Length not stated
  6. letters to the editorLetters to the Editor should describe timely issues related to a previous publication. These letters should use constructive and professional comments to expand…main text ≤ 800 words · figures and tables ≤ 1 · references ≤ 10
  7. meta-analysisPlease ensure that any manuscript you submit to CSP conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internation…Length not stated
  8. mini-reviewMini-review Unstructured; No more than 250 words ~ 2 ~ 3000 words; Structured as Introduction, main body, and Conclusions ~ 70Length not stated
  9. opinionation, Discussion, and Conclusions ~ 25 Opinion ~ 2 ~ 1500 words; Unstructured ~ 20 *Word count includes the main body of thmain text ≤ 1,500 words · figures and tables ≤ 2 · references ≤ 20
  10. original articleOriginal research manuscripts should describe experimental and/or clinical studies in biomedicine, including exploratory and hypothesis-driven studies of basic …main text ≤ 5,000 words · figures and tables ≤ 8 · references ≤ 50
  11. original researchPlease ensure that any manuscript you submit to CSP conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internation…Length not stated
  12. research letterResearch Letter ~ 3 ~ 1500 words; Unstructured ~ 20Length not stated
  13. reviewPlease ensure that any manuscript you submit to CSP conforms to the recommendations for ethics of the Committee on Publication Ethics (COPE) and the Internation…main text ≤ 3,000 words · figures and tables ≤ 10 · references ≤ 300
  14. systematic reviewA systematic review paper, as defined by the Cochrane Collaboration, is a review of a clearly formulated question that uses explicit, systematic methods to iden…main text ≤ 5,000 words · figures and tables ≤ 8 · references ≤ 70
  15. systematic review and meta-analysisSystematic Review and Meta-analysis Structured with Background and objectives, Methods, Results, and Conclusions; No more than 250 words ~ 8 ~ 5000 words; Struc…Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Preprints, Self-archiving, Trial registration / reporting guidelines
AI use Use of AI Tools by Reviewers

Manuscripts under review are confidential. Reviewers must not upload unpublished manuscripts, figures, tables, supplementary files, review reports, or any confidential manuscript-related information to public AI platforms.

Source ↗Publisher website ·
Authorship Author Contributions

The Authors’ Contributions should be provided in paragraph form following the authors’ names and affiliations and corresponding author(s)’ information. The manner in which each author was involved with the study or preparation of the manuscript is listed with the author’s name (shown as initials, within parentheses). Contributions that are acceptable for inclusion as an author are: study design, p…

Source ↗Publisher website ·
Conflicts of interest Conflict of Interest

All authors must check the ICMJE’s unified disclosure form. Each author should check the form to disclose any potential conflict of interest and is responsible for the accuracy and completeness of the provided information. The ICMJE’s form can be downloaded here.

Source ↗Publisher website ·
Data availability Data Sharing Statement

A Data Sharing Statement is required for research articles through which readers will know how to access the shared data. Sample wording: The [TYPE, such as technical appendix, statistical code, or dataset] data used to support the findings of this study have been deposited in the [NAME] repository ([DOI or other persistent identifier]); The [TYPE] data used to support the findings of this study a…

Source ↗Publisher website ·
License & copyright Copyright

Authors retain copyright Model summary

The copyright on all published articles will be retained by the authors unless stated otherwise. Authors grant CSP the sole, worldwide, and exclusive right to publish (i.e., print, publish, sell, and otherwise commercially exploit), reproduce, display, and store the published articles.

Source ↗Publisher website ·
Open access Open Access

Open access under CC BY-NC 4.0 license Model summary

Cancer Screening and Prevention (CSP) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open a…

Source ↗Publisher website ·
Peer review Peer Review & Editorial Process

Format-free initial submission Model summary

The objective of the peer review process is to ensure the integrity and transparency of the research objectives, data, and conclusions.Editorial ProcessAll articles, solicited and unsolicited, that are submitted to CSP will be subject to the following double blind peer review process, meaning that the author does not know the identity of the reviewer, and vice versa.Step 1: Upon submission, the ed…

Source ↗Publisher website ·
Plagiarism Types of Plagiarism

Plagiarism screening via Crossref Similarity Check Model summary

Plagiarism is defined by the CSP as the use of information, including textual descriptions, figures/tables and data, from a previously published document without proper citation or reference to the original source. All submitted manuscripts will be checked using plagiarism detection software (Crossref Similarity Check).

Source ↗Publisher website ·
Preprints Preprint version

A preprint is the version of an article before peer review. Authors are not requested to remove a preprint from a not-for-profit preprint server before submission. Upon acceptance, we recommend including an acknowledgment of acceptance on the first page, as follows:

Source ↗Publisher website ·
Self-archiving Self-archiving Policy

Self-archiving permitted without embargo Model summary

Authors of articles published in CSP are permitted to self-archive the preprint version of the article at any time, and may self-archive the postprint and published version without embargo.

Source ↗Publisher website ·
Trial registration / reporting guidelines Study Reporting Guidelines

To enhance the quality and transparency of health research, CSP requires all investigators to prepare articles according to the appropriate EQUATOR research reporting guidelines. Each submission of an original article/systematic review/meta-analysis/case report/study protocol should be accompanied by an appropriate checklist as listed below. Authors can find more guidelines at EQUATOR and should i…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Xia & He Publishing Inc.
Country or region
USA
Language
English
Frequency
Quarterly
Founded
2022
ISSN
2993-6314
Electronic ISSN
2835-3315
Official links

FAQ

Frequently asked questions about Cancer Screening and Prevention

How long does peer review take at Cancer Screening and Prevention?

The publisher reports about 20 days (submission to first decision); first decisions include desk rejections; the community-reported acceptance is “58%”; the journal's website gives an acceptance rate of 58%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Cancer Screening and Prevention?

According to the journal's author guidelines: Reference style: Vancouver; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Is Cancer Screening and Prevention open access, and what is the APC?

Cancer Screening and Prevention is a fully open-access journal. APC about USD 680.

Sources and updates

The facts on this page come from LetPub, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .